APA引文

Zhang, H., Yang, Y., Li, J., Wang, M., Saravanan, K. M., Wei, J., . . . Sciences, S. o. B. (2021). A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro.

Chicago Style Citation

Zhang, Haiping, et al. A Novel Virtual Screening Procedure Identifies Pralatrexate As Inhibitor of SARS-CoV-2 RdRp and It Reduces Viral Replication in Vitro. 2021.

MLA引文

Zhang, Haiping, et al. A Novel Virtual Screening Procedure Identifies Pralatrexate As Inhibitor of SARS-CoV-2 RdRp and It Reduces Viral Replication in Vitro. 2021.